Susquehanna International Group
NAMSW icon

Susquehanna International Group’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Susquehanna International Group’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,319
Closed -$57.3K – 12928
2023
Q4 		$57.3K Buy
+18,319
New +$35.9K ﹤0.01% 11663

Other funds holding NAMSW

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
GTS Securities
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Monashee Investment Management
Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Vestcor Inc
Vestcor Inc Fredericton, New Brunswick, Canada $4B AUM 28.69% 1-Year Est. Return

Susquehanna International Group's NAMSW Position: Q1 2024 in Review

Susquehanna International Group sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q1 2024, closing a stake of 18,319 shares — an estimated $57.3K sold.

Susquehanna International Group first reported a position in NAMSW in Q4 2023 and held it in 1 quarter. The position peaked at $57.3K in Q4 2023. 11 funds tracked by Wall St. Rank hold NAMSW as of Q1 2024.

  • Susquehanna International Group reported no remaining NewAmsterdam Pharma Warrant position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 18,319 NewAmsterdam Pharma Warrant shares in Q1 2024, an estimated $57.3K.
  • Susquehanna International Group first reported a position in NewAmsterdam Pharma Warrant in Q4 2023 and held it in 1 quarter.
  • Susquehanna International Group's NewAmsterdam Pharma Warrant position peaked at $57.3K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.